Related Experiment Video
Updated: Mar 10, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Novel Use of an Orbital Atherectomy Device for In-Stent Restenosis: Lessons Learned
K Shaikh1, S Kelly1, M Gedela1
1USD Department of Medicine, Division of Cardiology, Sioux Falls, SD, USA.
Orbital atherectomy system (OAS) shows potential for treating in-stent restenosis (ISR) in heavily calcified lesions. However, device failure can occur due to interactions between the device and stent during withdrawal.
Area of Science:
- Interventional Cardiology
- Cardiovascular Disease Management
Background:
- In-stent restenosis (ISR) in heavily calcified lesions poses a significant challenge in cardiovascular interventions.
- Managing ISR is complex due to limitations in current therapies and the presence of substantial calcium burden.
Purpose of the Study:
- To present a case study on the management of ISR in a high-risk patient with complex coronary artery disease.
- To evaluate the efficacy and potential complications of using an orbital atherectomy system (OAS) for ISR with calcified lesions.
Main Methods:
- A 67-year-old male patient with multiple comorbidities underwent treatment for acute coronary syndrome.
- Orbital atherectomy system (OAS) was utilized to address in-stent restenosis (ISR) in heavily calcified lesions.
- Device-stent interaction and subsequent device failure were observed during the procedure.
Main Results:
- The orbital atherectomy system (OAS) initially improved luminal patency in the ISR lesion.
- A critical device/stent interaction occurred during device withdrawal, leading to device failure.
- The case highlights the technical challenges associated with managing ISR in calcified lesions.
Conclusions:
- Orbital atherectomy system (OAS) may be effective for reestablishing patency in ISR lesions, particularly those with heavy calcification.
- Device-stent interactions represent a potential complication that requires careful consideration during OAS use for ISR.
- Further research is needed to optimize management strategies for ISR in complex coronary lesions.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
08:28Monitoring the Wall Mechanics During Stent Deployment in a Vessel
Published on: May 8, 2012
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...